edoc

Items where Author is "Rothschild, S. I."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2018 | 2016
Number of items: 5.

2018

Tondorf, T. and Grossert, A. and Rothschild, S. I. and Koller, M. T. and Rochlitz, C. and Kiss, A. and Schaefert, R. and Meinlschmidt, G. and Hunziker, S. and Zwahlen, D.. (2018) Focusing on cancer patients' intentions to use psychooncological support: A longitudinal, mixed-methods study. Psycho-Oncology, 27 (6). pp. 1656-1663.

2016

Rothschild, S. I. and Hagmann, R. and Zippelius, A.. (2016) 92P: Validation of prognostic scores in small cell lung cancer. J Thorac Oncol, 11 (4 Suppl). pp. 96-97.

Ruiz, C. and Kustermann, S. and Pietilae, E. and Vlajnic, T. and Baschiera, B. and Arabi, L. and Lorber, T. and Oeggerli, M. and Savic, S. and Obermann, E. and Singer, T. and Rothschild, S. I. and Zippelius, A. and Roth, A. B. and Bubendorf, L.. (2016) Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine. PLoS One, 11 (8). e0160807.

Schlosser, H. A. and Drebber, U. and Kloth, M. and Thelen, M. and Rothschild, S. I. and Haase, S. and Garcia-Marquez, M. and Wennhold, K. and Berlth, F. and Urbanski, A. and Alakus, H. and Schauss, A. and Shimabukuro-Vornhagen, A. and Theurich, S. and Warnecke-Ebertz, U. and Stippel, D. L. and Zippelius, A. and Buttner, R. and Hallek, M. and Holscher, A. H. and Zander, T. and Monig, S. P. and von Bergwelt-Baildon, M.. (2016) Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma. Oncoimmunology, 5 (5). e1100789.

Theurich, S. and Rothschild, S. I. and Hoffmann, M. and Fabri, M. and Sommer, A. and Garcia-Marquez, M. and Thelen, M. and Schill, C. and Merki, R. and Schmid, T. and Koeberle, D. and Zippelius, A. and Baues, C. and Mauch, C. and Tigges, C. and Kreuter, A. and Borggrefe, J. and von Bergwelt-Baildon, M. and Schlaak, M.. (2016) Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma. Cancer Immunol Res, 4 (9). pp. 744-754.

This list was generated on Fri Apr 19 19:49:57 2024 CEST.